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PRESENTATION of CASE
A
41-year-old non-Hispanic white
woman, accompanied by her psy-
chiatrist, presented for immunologic
consultation with an armload of medical
records. The patient’s primary concerns were
environmental mold exposure and a produc-
tive cough attributed to recurrent upper and
lower respiratory tract infections. Although
initially relating the beginning of her infections
to mold exposure over the previous four years,
the patient had experienced frequent respira-
tory tract infections since childhood, including
recurrent otitis media, mastoiditis, and two
episodes of pneumonia. The patient also
claimed to have congenital granulocytopenia,
specifically Kostmann syndrome.
The patient expressed particular concern
about ‘‘bowel problems,’’ which she claimed
manifested as ‘‘steatorrhea,’’ inability to gain
weight, and a need to eat every three to four
hours to stave off emotional agitation. The
patient described her stools as ‘‘rock hard’’ to
‘‘slimy.’’ Several gastroenterologists had eval-
uated the patient over the years, and results of
endoscopies and biopsies ruled out celiac
disease, chronic infections, and inflammatory
bowel disease. The patient provided a list of
psychotropic medications prescribed for her
‘‘atypical bipolar disorder’’ that included her
specific comments regarding each (Table 1). At
herinitialvisit,thepatientwastakingvitaminC
supplements, acidophilus, and bovine colos-
trum. Family history revealed paternal alcohol
abuse and kidney stones, and maternal ‘‘syn-
thetic chemical sensitivity’’ and hypoglycemia.
No family members had documented intesti-
nal or infectious disorders.
On examination, the patient was well
oriented, petite, and anxious. Her height and
weight were 158.4 cm and 45.9 kg, respec-
tively. Her blood pressure was 107/64 mm Hg.
There was no evidence of active upper or
lower respiratory tract infection. Her cardio-
vascular, abdominal, and lymph node exami-
nations were normal. There were no focal
neurologic abnormalities. However, the pa-
tient displayed labile emotions and required
frequent calming by her psychiatrist.
Laboratory studies performed approxi-
mately two years previously revealed the
following: hematocrit, 0.42; hemoglobin, 138
g/l; white blood cell count, 2.4 3 10
9/l;
absolute neutrophil count (ANC), 0.576 3 10
9
/l; serum IgG, 5.8 g/l (normal ¼ 6.13–12.9 g/l);
normal T cell subsets; normal blood chemistry
profile; negative antineutrophil antibodies;
and negative hepatitis B and C serologies.
One year later, the patient’s ANC was 0.208 3
10
9/l. Antibody responses to diphtheria and
tetanus toxoid vaccines were normal, but
antibody responses to 12 pneumococcal
serotypes, tested following immunization with
unconjugated 23-valent pneumococcal vac-
cine, were absent. Laboratory studies at initial
consultation confirmed neutropenia (ANC,
0.351 3 10
9/l), borderline IgG (6.10 g/l), and
absent pneumococcal antibody levels. Pan-
creatic exocrine insufficiency was demonstra-
ted by a low stool pancreatic elastase level (93
mcg/g; normal is greater than 200 mcg/g).
Despite confounding emotional issues and
exaggerated concerns regarding environmen-
tal mold exposure, the patient’s chronic
neutropenia, malabsorption, and subtle im-
mune deficiency were suggestive of a unify-
ing diagnosis: Shwachman-Diamond
syndrome (SDS) [1]. Genomic analysis was
performed by GeneDx, Gaithersburg, Mary-
land, United States. Two mutations were
identified in the patient’s DNA sample and
confirmed by restriction enzyme analysis of a
second DNA amplification. Both mutations
mimic the SBDS pseudogene and have been
seen in numerous patients with SDS [2]. The
mutations are designated c.183_184 TA to CT,
and IVS2þ2 T to C. The former mutation
causes a chain termination mutation in exon 2
at codon 62, and the latter causes aberrant
splicing of the adjacent intron 2. The latter
mutation is also known as c.258þ2 T to C. The
most likely interpretation of this finding is SDS
compound heterozygosity, with a different
SBDS mutation inherited from each parent.
The patient has not been seen again at this
institution since the diagnosis was made.
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For over 40 years, this patient’s primary diagnosis was
unsuspected. Multiple specialty consultations failed to recog-
nize the importance of complaints affecting organ systems
outside the areas of special interest. The patient’s psychiatric
history and emotional lability complicated assessment, and
likely led to the suspicion that her symptoms were psycho-
somatic.
The attribution of a ‘‘weakened immune system’’ to the
presence of home mold contamination led to the patient’s
referral to a center that deals in both pediatric and adult
immune dysfunctions. SDS was suspected, and the diagnosis
was conﬁrmed with genetic analysis for SBDS gene mutations.
SDS is an autosomal recessive disorder with clinical
features that include pancreatic exocrine insufﬁciency,
dysfunctional hematopoiesis, and skeletal abnormalities
[1,3]. Cases of SDS with humoral immune deﬁciency similar
to that identiﬁed in this patient have been described
previously [4,5]. The disorder has been complicated by
leukemia [6], and described as an inherited pre-leukemic
bone marrow failure disorder [7]. Until recently, the diagnosis
of SDS was based on clinical characteristics in children with
growth failure that resembles that of cystic ﬁbrosis [1].
Two major internal medicine textbooks [8,9] do not index
SDS in the differential diagnosis of either leucopenia or
pancreatic exocrine insufﬁciency, and it is likely that SDS is
more common in adults than generally diagnosed.
In 2003, Booncock et al. reported that mutations in a
previously uncharacterized gene, SBDS, were associated with
SDS [2]. Recent work demonstrated that the SBDS protein is
involved in RNA metabolism [10], yet the speciﬁc pathways
leading from genetic mutations to clinical manifestations
have not been delineated. Of particular interest is the ﬁnding
that SDS-associated bone marrow failure appears to be
caused by increased apoptosis associated with hyperactiva-
tion of the Fas signaling pathway [11]. Perhaps RNA
metabolic defects in hematopoetic, skeletal, and exocrine
pancreatic progenitors induce up-regulation of Fas expres-
sion and programmed cell death in the speciﬁc target cells.
The increasing availability of genetic assays, albeit tem-
pered by cost in many circumstances, allows for the deﬁnitive
diagnosis of genetic conditions, such as SDS, in atypical
patients. In the present case, such an assay was particularly
useful for identifying a speciﬁc pathophysiologic process in a
patient with multiple somatic complaints, a complex psychi-
atric condition, and a genetic ‘‘disease of childhood.’’
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Learning Points
  Shwachman-Diamond syndrome should be considered in the
differential diagnosis of neutropenia, recurrent respiratory tract
infections, and fat malabsorption, and strongly suspected when
all three features are present in a single patient.
  ‘‘Pediatric’’ genetic diseases are not limited to children.
Reliance on clinical descriptions of genetic disorders is likely to
lead to underdiagnosis of adult patients with less than classical
findings.
  The availability of reliable genetic testing in both academic and
commercial settings allows for the definitive diagnosis of diseases
previously classified on clinical criteria only.
  A rigorous search for underlying medical conditions may be
appropriate even in patients with multiple somatic complaints
and psychiatric disorders.
Table 1. Patient’s List of Previously Prescribed Psychotropic
Agents and Her Comments Regarding Each
Drug Comment Drug Comment
Thorazine Too groggy Ritalin Paranoia
Valium Too irritable and/or groggy Imipramine No Response
Xanax More anxiety Nardil Dizzy/nausea
Lithobid No response Prozac Mania? Too hyper
Lithium No response Acohil No response
Dicylomine No response Melloril Too irritable, too groggy
Navane Depression Resperdol Head banging
Artane Depression Buspar No response
Depakote Deadly Zoloff No response
Tegretol Deadly Symetrel No response
Norpramine No response Paxil Rash on breasts
Vestaril No response Serax No response
Halcion Headache/dizzy Zyprexa Deadly
Doral Deadly Neuarotin Deadly
DOI: 10.1371/journal.pmed.0030015.t001
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